Associatesfortune.com: Vivakor, Inc. & Angeion Corporation

Vivakor, Inc. (OTCBB: VIVK); Angeion Corporation (NASDAQ: ANGN)

AssociatesFortune.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our FREE newsletter. Please follow our thread on www.twitter.com at StockProfilerUS

Stock Profiler is pleased to introduce Vivakor, Inc. (OTCBB: VIVK) to the investment community. Please visit us at www.stockprofiler.us for more detailed information.

-------------------------------------------

Vivakor, Inc. closed at $0.45 Wednesday, trading 13,400 shares.

Company News- November 4, 2009: CEO of Vivakor, Inc. (OTCBB: VIVK) to Conduct Exclusive Webcast Interview with The Green Baron Report; New "Stock Pick" Coverage Initiated

Vivakor, Inc. (OTCBB: VIVK), a biomedical/biotechnology innovation company, announced yesterday that its Executive Chairman Matt Nicosia will conduct an exclusive new audio-taped webcast interview so that VIVK shareholders and the investment community can learn more about the Company's recently developments and growth plans. Unrestricted access to the webcast will be available beginning on Tuesday, November 10 at www.TheGreenBaron.com. Investors who wish to receive The Green Baron Report for free can join at http://www.thegreenbaron.com/Join.htm.

To read the full news release, go to www.stockprofiler.us, click the Headline Tab, enter the ticker symbol and click the news link.

About Vivakor, Inc.

Vivakor is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. The R&D Core at Vivakor (the idea hub) innovates, develops and validates biomedical devices and biotechnologies. Commercialization of Vivakor technologies is accomplished through partnerships with manufacturers and niche-industry marketing and distribution leaders. Vivakor generates revenues through the licensing or sale of its technologies. Vivakor is preparing a portfolio of IP and subsidiaries. These will focus on the commercialization of technologies developed by Vivakor. More information can be found about Vivakor at www.vivakor.com.

-------------------------------------------

Angeion Corporation closed at $3.52 Wednesday, trading 6,000 shares.

Company News- November 5, 2009: Angeion Corporation to Exhibit at MEDICA 2009

Angeion Corporation (NASDAQ: ANGN) announced earlier today that it will be showcasing its flagship line of MedGraphics cardiorespiratory diagnostic systems at the MEDICA 2009 International Trade Fair. The event is taking place at the Messe Dusseldorf, November 18-21, 2009, in Dusseldorf, Germany.

To read the full news release, go to www.stockprofiler.us, click the Headline Tab, enter the ticker symbol and click the news link.

About Angeion Corporation

Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (www.medgraphics.com) and New Leaf (www.newleaffitness.com) brand and trade names. These cardiorespiratory diagnostic systems have a wide range of applications in healthcare as well as health and fitness. The Company's products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians' offices, pharmaceutical companies, medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit www.angeion.com.

-------------------------------------------

The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. AssociatesFortune.com is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.fastmoneytalk.com, www.markettelegraph.com, www.thewallstreetleader.com and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.

CONTACT: E-mail: info@stockprofiler.us Website: www.associatesfortune.com

Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes, Media Coverage, Google Finance, Google Analytics, Google, Yahoo Finance, Yahoo, MSNBC, Search Engine, AOL Finance, AOL, Market Wire, Businesswire, PR Newswire Alphatrade, Comtex, Comtex A, Comtex B, Zacks, Real Trader, Market News Publications, AFX U.K., Future World, JAGNotes.com, Internetwire, EURO PR News, First Call, PrimeZone, U.S. News, Forbes, Track Notes

CONTACT: Associatesfortune.com e-mail: info@stockprofiler.us WWW: http://www.associatesfortune.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: acquisition, advisor, biomedical, biotechnology, broker, ceo, clinical, community, dealer, e-mail, euro, executive, exercise, finance, fitness, germany, graphics, health, healthcare, International trade, investment, investment opinion, manufacturer, market, marketing, media, medical, medicine, nasdaq, optics, pharmaceuticals, physicians, products, research, securities, small cap, technology, track, trade, university, web